PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO

Argenx is off to the races with the launch of its new med Vyvgart. With its first FDA-approved drug Vyvgart now rolling out, Argenx is charting a course to become an...
Continue Reading →
Quotient